Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Testing effectiveness (Phase 2)Ended earlyNCT01624090What this trial is testingMithramycin for Lung, Esophagus, and Other Chest CancersWho this might be right forLung CancerEsophageal CancerMesothelioma+2 more National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062What this trial is testingSYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.Who this might be right forEsophageal Squamous Cell Carcinoma CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT02350517What this trial is testingEndostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Yuhong Li 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Early research (Phase 1)Looking for participantsNCT05262491What this trial is testingBL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid TumorWho this might be right forGastrointestinal Tumor Sichuan Baili Pharmaceutical Co., Ltd. 96
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)UnknownNCT05737563What this trial is testingPD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Abdominal Stage 0 Sun Yat-sen University 380
Large-scale testing (Phase 3)Looking for participantsNCT06138028What this trial is testingSintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal CancerWho this might be right forMetastatic Esophageal Squamous Cell Carcinoma Qingdao Central Hospital 90
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Not applicableLooking for participantsNCT02838836What this trial is testingTumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersWho this might be right forNon-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more University of Missouri-Columbia 620
Testing effectiveness (Phase 2)Looking for participantsNCT07102901What this trial is testingSafety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction AdenocarcinomaWho this might be right forAdvanced Gastric CancerMetastatic Gastric CancerGastroesophageal Junction Adenocarcinoma Jiangsu HengRui Medicine Co., Ltd. 351
Not applicableNot Yet RecruitingNCT07822906What this trial is testingRisk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and SurgeryWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Peking University Cancer Hospital & Institute 100
Not applicableUnknownNCT04566367What this trial is testingBlue Laser Imaging (BLI) for Detection of Secondary Head and Neck CancerWho this might be right forHead Neck CancerEsophageal CancerGastrostomy Georg Dultz 140
Testing effectiveness (Phase 2)Study completedNCT02689284What this trial is testingCombination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerStomach CancerEsophageal Cancer MacroGenics 95
Large-scale testing (Phase 3)Study completedNCT02564263What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)Who this might be right forEsophageal CarcinomaEsophagogastric Junction Carcinoma Merck Sharp & Dohme LLC 628
Large-scale testing (Phase 3)Looking for participantsNCT07392892What this trial is testingSymbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerWho this might be right forUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaMetastatic Gastric CancerGastroesophageal Junction Cancer+1 more Pfizer 840
Early research (Phase 1)UnknownNCT05927844What this trial is testingXH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT05572684What this trial is testingA Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsMicrosatellite Instability LowMicrosatellite Instability High+9 more NextCure, Inc. 97